Guggenheim Capital LLC Horizon Therapeutics Public LTD CO Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $2.08 Million - $2.43 Million	-21,036 Reduced 36.23%	37,033 $4.28 Million
Q2 2023 Aug 11, 2023	SELL	$96.34 - $112.38 $1.01 Million - $1.18 Million	-10,458 Reduced 15.26%	58,069 $5.97 Million
Q1 2023 May 10, 2023	SELL	$107.32 - $113.5 $1.11 Million - $1.17 Million	-10,317 Reduced 13.09%	68,527 $7.48 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $697,582 - $1.27 Million	-11,181 Reduced 12.42%	78,844 $8.97 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $225,840 - $324,540	3,833 Added 4.45%	90,025 $5.57 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $1.08 Million - $1.58 Million	13,602 Added 18.74%	86,192 $6.88 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $1.38 Million - $1.75 Million	-15,945 Reduced 18.01%	72,590 $7.64 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $1.3 Million - $1.58 Million	-13,159 Reduced 12.94%	88,535 $9.54 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $1.28 Million - $1.54 Million	13,981 Added 15.94%	101,694 $11.1 Million
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $8,882 - $9,879	103 Added 0.12%	87,713 $8.21 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $201,411 - $267,725	-2,804 Reduced 3.1%	87,610 $8.06 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $299,222 - $376,885	4,466 Added 5.2%	90,414 $6.61 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $1.84 Million - $2.66 Million	-33,326 Reduced 27.94%	85,948 $6.68 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $3.25 Million - $6.14 Million	107,759 Added 935.81%	119,274 $6.63 Million
Q1 2020 Jun 02, 2020	BUY	$24.87 - $38.56 $75,853 - $117,608	3,050 Added 36.03%	11,515 $341,000
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $215,264 - $310,411	8,465 New	8,465 $306,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account